Performance of Procalcitonin to Distinguish Fungal from Bacterial Infections in Patients with Systemic Lupus Erythematosus

References

• Li PH, Lau CS. Lupus in the far east: a modern epidemic. Int J Rheum Dis. 2017;20(5):523–525. doi:10.1111/1756-185X.1311528597499
   PubMed Web of Science ®Google Scholar
• Fors Nieves CE, Izmirly PM. Mortality in systemic lupus erythematosus: an updated review. Curr Rheumatol Rep. 2016;18(4):21. doi:10.1007/s11926-016-0571-226984805
   PubMed Web of Science ®Google Scholar
• Adwan MH, Qasem U, Mustafa KN. In-hospital mortality in patients with systemic lupus erythematosus: a study from Jordan 2002–2017. Rheumatol Int. 2020;40(5):711–717. doi:10.1007/s00296-020-04538-z32146489
   PubMed Web of Science ®Google Scholar
• Moghaddam B, Marozoff S, Li L, et al. All-cause and cause-specific mortality in systemic lupus erythematosus: a Population-based Study. Rheumatology. 2021. doi:10.1093/rheumatology/keab362
   Web of Science ®Google Scholar
• Garris C, Jhingran P, Bass D, et al. Healthcare utilization and cost of systemic lupus erythematosus in a US managed care health plan. J Med Econ. 2013;16(5):667–677. doi:10.3111/13696998.2013.77827023425294
   PubMedGoogle Scholar
• Nagai Y, Yokogawa N, Shimada K, et al. Characteristics and risk factors of an emergency department visit in patients with systemic lupus erythematosus. Rheumatol Int. 2019;39(9):1567–1573. doi:10.1007/s00296-019-04377-731309295
   PubMed Web of Science ®Google Scholar
• Hoeboer SH, van der Geest PJ, Nieboer D, et al. The diagnostic accuracy of procalcitonin for bacteraemia: a systematic review and meta-analysis. Clin Microbiol Infect. 2015;21(5):474–481. doi:10.1016/j.cmi.2014.12.02625726038
   PubMed Web of Science ®Google Scholar
• Tektonidou MG, Ward MM. Validation of new biomarkers in systemic autoimmune diseases. Nat Rev Rheumatol. 2011;7(12):708–717. doi:10.1038/nrrheum.2011.15722045310
   PubMed Web of Science ®Google Scholar
• Brodska H, Malickova K, Adamkova V, et al. Significantly higher procalcitonin levels could differentiate Gram-negative sepsis from Gram-positive and fungal sepsis. Clin Exp Med. 2013;13(3):165–170. doi:10.1007/s10238-012-0191-822644264
   PubMed Web of Science ®Google Scholar
• Shin KC, Lee YJ, Kang SW, et al. Serum procalcitonin measurement for detection of intercurrent infection in febrile patients with SLE. Ann Rheum Dis. 2001;60(10):988–989. doi:10.1136/ard.60.10.98811589181
   PubMed Web of Science ®Google Scholar
• Chen D, Xie J, Chen H, et al. Infection in southern Chinese patients with systemic lupus erythematosus: spectrum, drug resistance, outcomes, and risk factors. J Rheumatol. 2016;43(9):1650–1656. doi:10.3899/jrheum.15152327307524
   PubMed Web of Science ®Google Scholar
• Serio I, Arnaud L, Mathian A, et al. Can procalcitonin be used to distinguish between disease flare and infection in patients with systemic lupus erythematosus: a systematic literature review. Clin Rheumatol. 2014;33(9):1209–1215. doi:10.1007/s10067-014-2738-425064130
   PubMed Web of Science ®Google Scholar
• Lanoix JP, Bourgeois AM, Schmidt J, et al. Serum procalcitonin does not differentiate between infection and disease flare in patients with systemic lupus erythematosus. Lupus. 2011;20(2):125–130. doi:10.1177/096120331037886220937623
   PubMed Web of Science ®Google Scholar
• Wang J, Niu R, Jiang L, et al. The diagnostic values of C-reactive protein and procalcitonin in identifying systemic lupus erythematosus infection and disease activity. Medicine. 2019;98(33):e16798. doi:10.1097/MD.000000000001679831415387
   PubMed Web of Science ®Google Scholar
• Echeverri A, Naranjo-Escobar J, Posso-Osorio I, et al. Neutrophil CD64 expression, procalcitonin and presepsin are useful to differentiate infections from flares in SLE patients with SIRS. Lupus. 2018;27(7):1130–1139. doi:10.1177/096120331876374029540108
   PubMed Web of Science ®Google Scholar
• AlJarhi UM, Sadek KM, Darwish EM, et al. Evaluation of serum presepsin, procalcitonin, copeptin, and high-sensitivity C-reactive protein for differentiating bacterial infection from disease activity in Egyptian patients with systemic lupus erythematosus. Clin Rheumatol. 2021;40(5):1861–1869. doi:10.1007/s10067-020-05471-z33111183
   PubMed Web of Science ®Google Scholar
• Leli C, Ferranti M, Moretti A, et al. Procalcitonin levels in gram-positive, gram-negative, and fungal bloodstream infections. Dis Markers. 2015;2015:701480. doi:10.1155/2015/70148025852221
   PubMed Web of Science ®Google Scholar
• Thomas-Ruddel DO, Poidinger B, Kott M, et al. Influence of pathogen and focus of infection on procalcitonin values in sepsis patients with bacteremia or candidemia. Crit Care. 2018;22(1):128. doi:10.1186/s13054-018-2050-929753321
   PubMed Web of Science ®Google Scholar
• Plato A, Hardison SE, Brown GD. Pattern recognition receptors in antifungal immunity. Semin Immunopathol. 2015;37(2):97–106. doi:10.1007/s00281-014-0462-425420452
   PubMed Web of Science ®Google Scholar
• Akin H, Akalin H, Budak F, et al. Alterations of serum cytokine levels and their relation with inflammatory markers in candidemia. Med Mycol. 2015;53(3):258–268. doi:10.1093/mmy/myu08425627661
   PubMed Web of Science ®Google Scholar
• Li S, Rong H, Guo Q, et al. Serum procalcitonin levels distinguish Gram-negative bacterial sepsis from Gram-positive bacterial and fungal sepsis. J Res Med Sci. 2016;21(1):39. doi:10.4103/1735-1995.18399627904585
   PubMed Web of Science ®Google Scholar
• Giacobbe DR, Mikulska M, Tumbarello M, et al. Combined use of serum (1,3)-beta-D-glucan and procalcitonin for the early differential diagnosis between candidaemia and bacteraemia in intensive care units. Crit Care. 2017;21(1):176. doi:10.1186/s13054-017-1763-528693606
   PubMed Web of Science ®Google Scholar
• Yu J, Xu B, Huang Y, et al. Serum procalcitonin and C-reactive protein for differentiating bacterial infection from disease activity in patients with systemic lupus erythematosus. Mod Rheumatol. 2014;24(3):457–463. doi:10.3109/14397595.2013.84439124252006
   PubMed Web of Science ®Google Scholar
• Fan YC, Li WG, Zheng MH, et al. Invasive fungal infection in patients with systemic lupus erythematosus: experience from a single institute of Northern China. Gene. 2012;506(1):184–187. doi:10.1016/j.gene.2012.06.05922750799
   PubMed Web of Science ®Google Scholar
• Charles PE, Castro C, Ruiz-Santana S, et al. Serum procalcitonin levels in critically ill patients colonized with Candida spp: new clues for the early recognition of invasive candidiasis? Intensive Care Med. 2009;35(12):2146–2150. doi:10.1007/s00134-009-1623-019760210
   PubMed Web of Science ®Google Scholar